Metabolic adaptation of regenerative hematopoiesis depends on docking-independent mitochondrial connexin 43

A Abhishek K. Singh (Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustraβe 3, 14195 Berlin, Germany) A Angelo D’Alessandro A Ashley M. Wellendorf (4Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH) D Daniel Gonzalez-Nieto (5Department of Photon Technology and Bioengineering, Center for Biomedical Technology, Universidad Politécnica, Madrid, Spain) M Matthew Kofron (7Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH) M Monika Dzieciatkowska L Leo Mejia (1Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA) L Luis C. Barrio (8Unit of Experimental Neurology, Department of Research, Hospital Ramon y Cajal, Madrid, Spain) M Marie-Dominique Filippi (Cincinnati Children's Hospital Research Foundation) J Jose A. Cancelas (Dana-Farber Cancer Institute, Boston, Massachusetts, United States)

Abstract

Abstract Hematopoietic stem cells (HSCs) exhibit a distinctive antioxidant profile during steady-state and stress hematopoiesis. HSCs and multipotential progenitors (MPPs) are metabolically coupled to bone marrow mesenchymal stromal cells through mitochondrial transfer, a process dependent on hematopoietic connexin 43 (Cx43) and low adenosine monophosphate–activated protein kinase (AMPK) activity. However, the mechanism by which Cx43 preserves mitochondrial functionality in HSCs remains elusive. Here, through integrated transcriptomic, proteomic, metabolomic, phenotypic, and functional analyses of HSCs and their isolated mitochondria, we identified that Cx43 is present on the inner and outer mitochondrial membranes of HSCs/MPPs, in which it primarily regulates mitochondrial metabolism and adenosine triphosphate synthesis by preserving the mitochondrial cristae, activation of mitochondrial AMPK, and 2-oxoglutarate dehydrogenase, a rate-liming enzyme in tricarboxylic acid cycle and electron transfer chain. During replicative stress, Cx43-deficient HSCs/MPPs fail to adapt metabolically and accumulate mitochondrial Ca2+, leading to increased mitochondrial AMPK activity, mitochondrial fission, mitophagy, and production of reactive oxygen species, thereby limiting HSC/MPP regeneration potential. Disruption of hyperfragmentation of mitochondria and mitophagy by Drp1 dominant-negative mutant (Drp1K38A) or restoration of mitochondrial function through ex vivo heteroplasmy prevents the harmful effects of Cx43 deficiency on mitochondrial metabolism and restore HSC activity in serial transplantation experiments. Re-expression analysis of Cx43 structure-function mutants indicates that Cx43 hemichannels are sufficient to reset HSC mitochondrial metabolism, dynamics, Ca2+ levels, and regeneration capacity. This report defines the cell-autonomous mechanism of action behind the role of Cx43 in HSC activity and opens a venue to translational applications in transplantation.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue 19
Published November 06, 2025
Pages 2306-2321
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (10)

A

Abhishek K. Singh

Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustraβe 3, 14195 Berlin, Germany

A

Angelo D’Alessandro

A

Ashley M. Wellendorf

4Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH

D

Daniel Gonzalez-Nieto

5Department of Photon Technology and Bioengineering, Center for Biomedical Technology, Universidad Politécnica, Madrid, Spain

M

Matthew Kofron

7Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

M

Monika Dzieciatkowska

L

Leo Mejia

1Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA

L

Luis C. Barrio

8Unit of Experimental Neurology, Department of Research, Hospital Ramon y Cajal, Madrid, Spain

M

Marie-Dominique Filippi

Cincinnati Children's Hospital Research Foundation

J

Jose A. Cancelas

Dana-Farber Cancer Institute, Boston, Massachusetts, United States